In mice given both irrDaudi and CAR.CD19-T cells, we observed a significant increase in the occurrence of hemorrhagic areas in the CNS of mice developing CRS, as compared to control mice infused only with irrDaudi (Fig. 7b, c; p = 0.035). The gene discussed is CD19; the disease is congenital rubella syndrome.